Jennison Associates’s Globus Medical GMED Stock Holding History

Jennison Associates’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-16,175	Closed	-$684K	–	660
2019 Q2	$684K	Buy	16,175 +989	+7%	+$42.9K	﹤0.01%	608
2019 Q1	$750K	Sell	15,186 -4,116	-21%	-$186K	﹤0.01%	580
2018 Q4	$835K	Buy	19,302 +2,620	+16%	+$131K	﹤0.01%	554
2018 Q3	$947K	Sell	16,682 -217	-1%	-$11.4K	﹤0.01%	561
2018 Q2	$853K	Sell	16,899 -5,432	-24%	-$283K	﹤0.01%	575
2018 Q1	$1.11M	Sell	22,331 -707	-3%	-$33.2K	﹤0.01%	558
2017 Q4	$947K	Buy	23,038 +1,900	+9%	+$66.5K	﹤0.01%	584
2017 Q3	$628K	Buy	+21,138	New	+$645K	﹤0.01%	602
2016 Q2	–	Sell	-9,780	Closed	-$232K	–	642
2016 Q1	$232K	Buy	+9,780	New	+$239K	﹤0.01%	605

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Jennison Associates's GMED Position: Q3 2019 in Review

Jennison Associates sold out of Globus Medical (GMED) in Q3 2019, closing a stake of 16,175 shares — an estimated $684K sold.

Jennison Associates first reported a position in GMED in Q1 2016 and held it in 9 quarters. The position peaked at $1.11M in Q1 2018. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

Jennison Associates reported no remaining Globus Medical position as of Q3 2019 after selling out during the quarter.
Jennison Associates sold 16,175 Globus Medical shares in Q3 2019, an estimated $684K.
Jennison Associates first reported a position in Globus Medical in Q1 2016 and held it in 9 quarters.
Jennison Associates's Globus Medical position peaked at $1.11M in Q1 2018.
268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on Jennison Associates's 13F filing for Q3 2019, filed 8 Nov 2019.